Go to deals
Healthcare

Bluebird Care has been acquired by Interim Healthcare Inc.

US-based care-at-home franchisor Interim Healthcare Inc. has acquired Bluebird Care, based in the UK, a national provider of care in the home. Financial details have not been provided.

Bluebird Care offers a unique service of tailored care visits from 30 minutes to full live-in support. The company has nearly 200 offices in the UK and the Republic of Ireland.

Founded in 1966, Interim Healthcare has more than 300 independently owned and operated franchise locations providing a variety of home health, senior care, hospice, palliative care, pediatric care and healthcare staffing services.

UK-based Oaklins Smith & Williamson, assisted by the team in Los Angeles, advised the seller in this transaction.

Parties

Talk to the deal team

Stuart Goodman

Partner
London, United Kingdom
Oaklins S&W

Gary Rabishaw

Managing Director
Los Angeles, United States
Oaklins Intrepid

Related deals

UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more
Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more